title: Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502).
abstract: BACKGROUND
  To prospectively determine the feasibility of sentinel lymph node biopsy (SLNB) in preoperatively diagnosed multiple unilateral synchronous invasive breast cancers.
  
  
  METHODS
  The Interest of Axillary Sentinel Lymph Node Biopsy in Multiple Invasive Breast Cancer (IGASSU) study was a prospective multi-institutional study with initial breast surgery, SLNB, and systematic axillary lymph node dissection (ALND). Patients eligible for the IGASSU study had an operable invasive multiple synchronous tumor (MST), defined as two or more physically separate invasive tumors in the same or different quadrant.
  
  
  RESULTS
  From 1 March 2006 to 31 August 2007, 216 patients were prospectively included from 16 institutions. Of these patients, 211 were assessable. The SLNB-identified rate was 93.4% (197 of 211). The false-negative rate (FNR) was 13.6% (14 of 103) [95% confidence interval (CI) 7% to 20%], and the accuracy was 92.9% (183 of 197) (95% CI 89% to 96%). In a univariate analysis, tumor location (only external location versus other location) was the only clinicopathological factor influencing the FNR [22% (11%-33%) versus 7% (4%-10%)], even then median aggregate histological tumor size was smaller in external tumors [17 mm (range 12-80 mm) versus 34 mm (range 8-90 mm), P = 0.016].
  
  
  CONCLUSIONS
  With a FNR of 13.6%, we do not recommend SLNB as a routine procedure for MST, even for small tumor.
authors.affiliation: Departments of Surgery and Oncology, Centre Oscar Lambret, Lille. Electronic address: s-giard@o-lambret.fr.
authors.forename: S
authors.initials: S
authors.lastname: Giard
authors.affiliation: Departments of Surgery and Oncology, Centre Oscar Lambret, Lille.
authors.forename: M-P
authors.initials: MP
authors.lastname: Chauvet
authors.affiliation: Departments of Surgery and Oncology, Centre Oscar Lambret, Lille.
authors.forename: N
authors.initials: N
authors.lastname: Penel
authors.affiliation: Department of Surgery, Centre Leon Berard, Lyon.
authors.forename: H
authors.initials: H
authors.lastname: Mignotte
authors.affiliation: Department of Surgery, Centre Claudius Regaud, Toulouse.
authors.forename: P
authors.initials: P
authors.lastname: Martel
authors.affiliation: Department of Surgery, Institut Bergonie, Bordeaux.
authors.forename: C
authors.initials: C
authors.lastname: Tunon de Lara
authors.affiliation: Department of Surgery, Centre Jean Perrin, Clermont-Ferrand.
authors.forename: P
authors.initials: P
authors.lastname: Gimbergues
authors.affiliation: Department of Surgery, Centre Henri Becquerel, Rouen.
authors.forename: P
authors.initials: P
authors.lastname: Dessogne
authors.affiliation: Department of Surgery, Centre Rene Gauducheau de Nantes, Saint Herblain.
authors.forename: J-M
authors.initials: JM
authors.lastname: Classe
authors.affiliation: Department of Surgery, Centre Paul Papin, Angers.
authors.forename: E
authors.initials: E
authors.lastname: Fondrinier
authors.affiliation: Department of Surgery, Clinique de Flandre, Coudekerque-Branche, France.
authors.forename: T
authors.initials: T
authors.lastname: Marmousez
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000473:pathology*; D005188:False Negative Reactions; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D021701:Sentinel Lymph Node Biopsy